Women face many of the same stroke risk factors as men, including high blood pressure, diabetes, and smoking, but they also carry a set of risks that are entirely unique to their biology. Hormonal shifts across a woman’s lifetime, from contraceptive use to pregnancy to menopause, create windows of elevated vulnerability that have no male equivalent. In the United States, stroke is the third leading cause of death in women compared with the fifth in men, and women account for roughly 55,000 more fatal strokes each year.
Why Women Face Higher Stroke Risk Overall
The lifetime risk of stroke for a 55-year-old woman in the U.S. is 20% to 21%, compared with 14% to 17% for a man the same age. Women tend to have their first stroke four to six years later in life than men, which means they’re often older and frailer when it happens. That age gap partly explains why strokes in women tend to be more disabling and more often fatal. But age alone doesn’t account for the difference. Women also accumulate risk factors that men simply don’t encounter.
Pregnancy as a Vascular Stress Test
Pregnancy forces the cardiovascular system to work harder, and the hormonal changes that come with it make blood more prone to clotting. The body produces higher levels of clotting factors in late pregnancy, and reduced blood flow in the lower legs adds to the problem. The highest-risk window is tight: the two days before through one day after delivery, when the stroke rate jumps to roughly nine times the normal rate for women of the same age. In the first six weeks after delivery, the risk remains about three times higher than baseline.
Preeclampsia and eclampsia, conditions marked by dangerously high blood pressure during pregnancy, are the strongest pregnancy-related stroke risk factors. They account for 24% to 48% of all pregnancy-associated strokes. The danger doesn’t end with delivery. Women who had preeclampsia carry a significantly higher risk of high blood pressure, heart disease, and stroke for the rest of their lives. The same is true for gestational diabetes, which raises long-term stroke and heart disease risk even after blood sugar returns to normal postpartum.
The 2024 AHA/ASA stroke prevention guidelines recommend that women who experienced these pregnancy complications be screened regularly for vascular risk factors going forward. Pregnancy history, in other words, is a meaningful part of a woman’s cardiovascular profile for decades.
Birth Control Pills and Stroke Risk
Combined oral contraceptives, the kind containing both estrogen and progestin, promote blood clotting. Modern formulations use far less estrogen than earlier versions (typically 30 to 35 micrograms of ethinyl estradiol, down from 80 to 100 in early pills), and the risk is lower than it once was. But even with today’s low-dose pills, the risk of ischemic stroke is roughly doubled compared with non-users.
The risk climbs sharply when other factors are layered on. Women who have migraines with aura and use combined oral contraceptives face about a sevenfold increase in ischemic stroke risk. Add smoking to that combination, and the relative risk jumps to approximately tenfold. For this reason, guidelines recommend that women over 35, smokers, and those who experience migraines with visual or neurological symptoms use progestin-only or non-hormonal contraception instead. Progestin-only methods have not been linked to increased stroke risk.
Migraine With Aura
Migraine with aura, the type that produces visual disturbances, tingling, or other neurological symptoms before the headache starts, roughly doubles a person’s risk of ischemic stroke. That association is strongest in women under 45. The mechanism isn’t fully understood, but the combination of blood vessel spasm, inflammation, and a tendency toward small blood clots during aura episodes likely plays a role. For women in this age group, migraine with aura is one of the most important modifiable risk factors to discuss with a doctor, particularly because it interacts so powerfully with oral contraceptive use and smoking.
Menopause and Estrogen Loss
Before menopause, estrogen appears to protect blood vessels. It improves the flexibility of artery walls, promotes healthy blood flow, and helps maintain favorable cholesterol levels. Animal studies show estrogen even reduces the extent of brain damage during experimental strokes. When estrogen levels drop at menopause, those protective effects diminish, and the rate of stroke in women begins to climb.
This led to the idea that replacing estrogen after menopause might preserve that protection. It didn’t work out that way. The Women’s Health Initiative, a large randomized trial, found that women taking oral estrogen plus progestin had a 31% higher risk of stroke overall and a 44% higher risk of ischemic stroke specifically. Other studies consistently show a 27% to 39% increase in stroke risk with oral postmenopausal hormone therapy. Early menopause (before age 45) and premature ovarian failure (before 40) are themselves associated with higher stroke risk, and the 2024 guidelines recommend screening women with these conditions for vascular risk factors.
Atrial Fibrillation Hits Women Harder
Atrial fibrillation, the most common heart rhythm disorder, is a major stroke cause in both sexes. But when women develop it, the consequences tend to be worse. Women with atrial fibrillation who have even one additional stroke risk factor face a higher chance of ischemic stroke than men in the same situation. When strokes do occur, they tend to be more severe and more disabling in women. Women are also less likely to recover fully afterward.
Part of this disparity comes down to treatment gaps. Women have historically been undertreated with blood thinners and are more likely to be prescribed doses that are too low. They’re less likely to receive clot-dissolving treatment during an acute stroke. After a stroke, women have higher rates of recurrence in the first 90 days, often because blood-thinning medication is interrupted or not restarted. These are not biological inevitabilities. They reflect patterns in how care is delivered.
Autoimmune Disease and Chronic Inflammation
Systemic lupus erythematosus (lupus) affects women about nine times more often than men, and it carries a meaningful stroke risk. The disease causes chronic inflammation of blood vessel walls, promotes premature hardening of the arteries, and triggers changes in the immune system that make blood more likely to clot. These effects persist throughout the course of the disease: inflammation-related clotting events are most common in the first five years after diagnosis, but accelerated plaque buildup in arteries is a lifelong concern. Long-term steroid use for lupus management adds to the problem by further increasing cardiovascular risk.
Symptoms Women Should Recognize
Women experience the classic stroke warning signs, including sudden facial drooping, arm weakness, and speech difficulty. But they’re also more likely than men to show less typical symptoms: sudden confusion, generalized fatigue, overall weakness not limited to one side, severe headache, a change in mental state, or loss of consciousness. These “generalized” symptoms aren’t linked to a specific area of the brain the way one-sided weakness is, which can make them easier to dismiss or misattribute to something else. Recognizing that stroke doesn’t always look like the textbook description is particularly important for women, since delays in getting treatment directly affect outcomes.